In vivo bioluminescence imaging for leptomeningeal dissemination of medulloblastoma in mouse models
暂无分享,去创建一个
D. Hwang | D. S. Lee | J. Y. Lee | K. Wang | Seung-Ki Kim | Sung-Hye Park | Hyun Jeong Oh | J. Phi | S. Choi | Pil Ae Kwak | Kyuwan Kim
[1] R. Young,et al. Extraneural metastases of medulloblastoma: Desmoplastic variants may have prolonged survival , 2015, Pediatric blood & cancer.
[2] Seung Jin Lee,et al. In Vivo Bioluminescence Imaging for Prolonged Survival of Transplanted Human Neural Stem Cells Using 3D Biocompatible Scaffold in Corticectomized Rat Model , 2014, PloS one.
[3] H. Hirai,et al. Distinct transduction profiles in the CNS via three injection routes of AAV9 and the application to generation of a neurodegenerative mouse model , 2014, Molecular therapy. Methods & clinical development.
[4] Maiken Nedergaard,et al. Paravascular microcirculation facilitates rapid lipid transport and astrocyte signaling in the brain , 2013, Scientific Reports.
[5] K. Wang,et al. ID3 contributes to cerebrospinal fluid seeding and poor prognosis in medulloblastoma , 2013, BMC Cancer.
[6] Helen Dacres,et al. Advantages of substituting bioluminescence for fluorescence in a resonance energy transfer-based periplasmic binding protein biosensor. , 2013, Biosensors & bioelectronics.
[7] S. Scherer,et al. Clonal Selection Drives Genetic Divergence of Metastatic Medulloblastoma , 2012, Nature.
[8] Hyunggee Kim,et al. Therapeutic targeting of subdural medulloblastomas using human neural stem cells expressing carboxylesterase , 2011, Cancer Gene Therapy.
[9] Chae-Yong Kim,et al. Cerebrospinal fluid M staging for medulloblastoma: reappraisal of Chang's M staging based on the CSF flow. , 2011, Neuro-oncology.
[10] J. Barbet,et al. The intraportal injection model for liver metastasis: advantages of associated bioluminescence to assess tumor growth and influences on tumor uptake of radiolabeled anti-carcinoembryonic antigen antibody , 2011, Nuclear medicine communications.
[11] D. Scherman,et al. Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models , 2010, Cancer Gene Therapy.
[12] J. Yoshida,et al. Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma , 2007, Gene Therapy.
[13] Seung-Ki Kim,et al. Human Neural Stem Cells Target Experimental Intracranial Medulloblastoma and Deliver a Therapeutic Gene Leading to Tumor Regression , 2006, Clinical Cancer Research.
[14] C. Lau,et al. Valproic Acid Prolongs Survival Time of Severe Combined Immunodeficient Mice Bearing Intracerebellar Orthotopic Medulloblastoma Xenografts , 2006, Clinical Cancer Research.
[15] I. B. Borel Rinkes,et al. Validation of bioluminescence imaging of colorectal liver metastases in the mouse. , 2004, The Journal of surgical research.
[16] M. Scott,et al. Altered neural cell fates and medulloblastoma in mouse patched mutants. , 1997, Science.
[17] Y. Maruyama,et al. Prognostic factors in medulloblastoma , 1982, American journal of clinical oncology.
[18] N. Saito,et al. Novel modified method for injection into the cerebrospinal fluid via the cerebellomedullary cistern in mice. , 2013, Acta neurobiologiae experimentalis.